ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Aarey Drugs & Pharmaceuticals Ltd filed its quarterly shareholding pattern. This is a routine regulatory compliance disclosure regarding the company's equity distribution.
The company has filed its quarterly shareholding pattern for the period ending June 30, 2026, as per regulatory requirements.
Aarey Drugs & Pharmaceuticals filed its Annual Secretarial Compliance Report for FY 2025-26. The report details regulatory compliance status and observations from the practicing company secretary.